SIM0270 not checked
Jiangsu Simcere Pharmaceutical Co., Ltd. · SCR6852
FollowEvery change as it happens, and a Monday email
Trials
4 active
5 in total
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “SIM0270 is an oral, selective estrogen receptor degrader (SERD)”In the company’s words, NCT05293964 on ClinicalTrials.gov
- Main trialPhase 3
- “This Phase III, randomized, open label, multicenter study will evaluate the efficacy and safety of SIM0270 combined with everolimus compared to physician's choice of treatment in subjects with ER+/HER2- locally advanced or metastatic breast cancer who have had previous treatment with CDK4/6 inhibitor.”In the company’s words, NCT06680921 on ClinicalTrials.gov
- Other names
- SCR6852
Other drugs for Locally Advanced or Metastatic Breast Cancer
- D-0502InventisBio Co., Ltd · Phase 3
- ElacestrantStemline Therapeutics, Inc. · Phase 3
- YL202MediLink Therapeutics (Suzhou) Co., Ltd. · Phase 3
- SPH4336Shanghai Pharmaceuticals Holding Co., Ltd · Phase 2/3
- PembrolizumabMerck & Co. · Phase 3
- NiraparibGSK · Phase 3
Coming up1
- 31 Aug 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 31 Aug 2028 | A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE) | |
| Phase 1Active, not recruiting | 31 Dec 2024 | Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer | |
| Phase 1Active, not recruiting | 31 Mar 2025 | Mass Balance Clinical Trial of SIM0270 | |
| Phase 1Recruiting | 30 Oct 2026 | An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants | |
| Phase 1Completed | 16 Oct 2024 | Evaluate the Effects of Food on the Pharmacokinetics of SIM0270 |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026